SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001662579-23-000061
Filing Date
2023-06-16
Accepted
2023-06-16 16:24:56
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686947089.html 4  
1 FORM 4 wk-form4_1686947089.xml 4 3935
  Complete submission text file 0001662579-23-000061.txt   5322
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4747 EXECUTIVE DRIVE SUITE 1150 SAN DIEGO CA 92121
Business Address
Bessen Laura (Reporting) CIK: 0001926815 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39567 | Film No.: 231021526